The independent source for health policy research, polling, and news.
12,961 - 12,980 of 112,407 Results
Merck agreed to license its covid treatment molnupiravir for production by third-party drugmakers so that it can be accessed more easily in 105 low- and middle-income countries. Separately, Novavax has applied for U.K. authorization of its covid vaccine, the first protein-based shot in Europe.
Aetna's Gene-based Cellular and Other Innovative Therapies network is aimed at curbing million-dollar costs of the gene therapy market. Separately, the National Institutes of Health and the Food and Drug Administration launched a public-private partnership to speed up gene treatments.
News outlets cover fresh moves in the legal battle over Texas' strict abortion law, including warnings that the model the state used to make the law work could spread to other states, and threaten other constitutional rights too. Abortion news also comes from Oregon and Ohio.
The passport has an "X" for its gender section, indicating the passport-bearer does not identify their gender in line with binary male/female types. Fast food from Domino's, McDonald's and other outlets has been shown to contain plastic phthalate contaminants, which have been linked to health issues.
TeamHealth is accused of tricking the health insurer into paying over $100 million in fraudulent claims. Among other corporate health care news, St. Francis-Emory Hospital in Columbus, Georgia, is getting a new owner, and Kosair Charities gifted $6.4 million to a children's spinal injury program.
Meanwhile, the White House indicated it might be more flexible in enforcing the requirements for federal workers. In other news, New Orleans lifts its requirement for wearing masks in public spaces.
State Supreme Court Judge Lizette Colon denied a request from New York City's largest police union to block Mayor Bill de Blasio's mandate that all municipal workers get at least one covid shot by Monday. Meanwhile, the head of the city's firefighter union said members should defy the mandate.
After meeting with House Democrats on Thursday morning, President Joe Biden is expected to outline a new framework for the social spending bill. Whether health measures like paid family leave and Medicare expansion will make the cut — and if progressives can support the plan drastically scaled back to satisfy two Senate moderates — is still a big unknown.
Earlier this month, the Centers for Disease Control and Prevention added mental illnesses to the list of health conditions that can put a person at risk for developing severe covid. That classification makes millions of Americans eligible to get a booster shot, under federal guidelines.
News outlets cover states' preparations for the next stage of combatting covid — shots for children ages 5 to 11 — but a new survey shows that a majority of parents are reluctant to give their children the vaccine, at least at first. Dr. Anthony Fauci is quoted as saying he'd give kids shots "in a second."
Through January 2021, at least 59,000 workers were infected with covid and 269 workers died at Tyson Foods, JBS USA, Cargill, National Beef and Smithfield Foods. Those figures are three times higher than previously thought.
The Food and Drug Administration finalized new regulations that include "black box" warnings on implant packaging and that plastic surgeons must run patients through a checklist of possible complications, including scarring, pain, rupture and a rare form of cancer.
Results from a clinical trial in Brazil indicate that fluvoxamine — a low-cost antidepressant that is commonly available in many countries — reduces the chances of hospitalization in patients with covid-19.
Editorial writers delve into these public health issues.
Opinion writers weigh in on delta and hybrid immunity.
Today's early morning highlights from the major news organizations.
Read recent commentaries about drug-cost issues.
Opinion writers delve into these covid, vaccine and mandate issues.
Editorial writers tackle medical distrust and addiction stigma.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
© 2026 KFF